Filing Details
- Accession Number:
- 0001140361-16-068373
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-03 07:28:51
- Reporting Period:
- 2016-06-01
- Filing Date:
- 2016-06-03
- Accepted Time:
- 2016-06-03 07:28:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1380187 | Daniel Abdun-Nabi | 400 Professional Dr, Suite 400 Gaithersburg MD 20879 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2016-06-01 | 8,699 | $43.74 | 170,966 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi.
- Consists of vested restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.56 to $43.94, inclusive.
Billionaire Hedge Funds
